The 8-hour MOUD Training - PART 1 - 12/18/2023 (counts towards the DEA’s 8-hour training requirement)-Presentation Slides

Presentation Slides - Part 1 with Dr. Morrone

Pdf Summary

This document discusses various aspects of treating opioid use disorder, including co-occurring psychiatric disorders, pain management for patients taking buprenorphine, treatment during pregnancy, treatment in adolescents, and treatment in patients with HIV. It also provides a case study of a patient with opioid use disorder and outlines their treatment plan.<br /><br />Co-occurring substance use and psychiatric disorders are common, and targeted treatment with medications like SSRIs can be effective. When managing pain in patients taking buprenorphine, caution is needed due to its unique pharmacological properties. Methadone and buprenorphine are recommended medications for pregnant individuals with opioid use disorder, and close monitoring is necessary. Adolescents with opioid use disorder should receive medication-assisted treatment combined with psychosocial interventions, and attention should be given to their mental health needs. Individuals with HIV and opioid use disorder require comprehensive, integrated care.<br /><br />In the given case study, the patient is a 35-year-old school teacher struggling with heroin use. The recommended treatment option is medication-assisted treatment using buprenorphine/naloxone. The goals of treatment include reducing or eliminating heroin use, improving functioning, and addressing any co-occurring mental health issues. The initial treatment plan may involve initiating buprenorphine/naloxone treatment, providing counseling and support services, and regularly monitoring progress.<br /><br />Management of opioid withdrawal may involve a gradual buprenorphine taper to transition the patient from heroin use to maintenance treatment. Regular urine drug testing can help monitor progress and ensure compliance. Comprehensive care and support, including counseling, relapse prevention strategies, and addressing social or environmental factors, are crucial for successful treatment and long-term recovery. Collaboration with healthcare providers and support networks is also beneficial.<br /><br />Overall, this document emphasizes the importance of comprehensive and individualized treatment for opioid use disorder, considering factors such as co-occurring conditions and pregnancy. It highlights medication-assisted treatment as an effective approach and emphasizes the need for ongoing support and monitoring for successful outcomes.

Keywords

opioid use disorder

co-occurring psychiatric disorders

pain management

buprenorphine

treatment during pregnancy

adolescent treatment

HIV and opioid use disorder

case study

medication-assisted treatment

comprehensive care